In all of the previously reported cases of T-lymphoblastic CML-BP, BCR-ABL1 gene fusion occurs at the BCR major breakpoint with a protein product of p210. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.